Onesource Specialty Pharma ONESOURCE.NS · INR

Its shares trade on NSE under the ticker ONESOURCE.NS. It has been listed since 24 January 2025. In the fiscal year to 31 March 2026, it reported revenue of ₹14.22bn and a net loss of ₹738.0m. At that date it held total assets of ₹82.10bn and shareholders' equity of ₹58.31bn.

Onesource Specialty Pharma Ltd is a IN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2025-01-24. OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. The company operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The firm specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. The company supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The firm caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Anurag BhaganiaChief Financial Officer
• Ms. Allada TrishaCompliance Officer, Company Secretary₹1.6m
• Neeraj SharmaManaging Director₹2.7m
• Pudhucode KannanWhole-Time Director, since 2021₹21.5m
• Mr. Bernhard BernhardChief Quality Officer
• Mr. Bhushan BopardikarDirector
• Arun PillaiDirector (Promoter)
• Mr. Bharat ShahDirector
• Mr. Deepak VaidyaIndependent Director
• Dr. Claudio AlbrechtAdditional Non-Executive Independent Director
• Mr. Vijay KarwalAdditional Non-Executive Independent Director
• Ms. Debarati SenAdditional Non-Executive Independent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.